153 related articles for article (PubMed ID: 34102344)
1. Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy.
Francis JH; Canestraro J; Haggag-Lindgren D; Harding JJ; Diamond EL; Drilon A; Li BT; Iyer G; Schram AM; Abramson DH
Ophthalmol Retina; 2021 Dec; 5(12):1187-1195. PubMed ID: 34102344
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy.
Francis JH; Habib LA; Abramson DH; Yannuzzi LA; Heinemann M; Gounder MM; Grisham RN; Postow MA; Shoushtari AN; Chi P; Segal NH; Yaeger R; Ho AL; Chapman PB; Catalanotti F
Ophthalmology; 2017 Dec; 124(12):1788-1798. PubMed ID: 28709702
[TBL] [Abstract][Full Text] [Related]
3. Subretinal Fluid Associated With MEK Inhibitor Use in the Treatment of Systemic Cancer.
Weber ML; Liang MC; Flaherty KT; Heier JS
JAMA Ophthalmol; 2016 Aug; 134(8):855-62. PubMed ID: 27309887
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor-Associated Retinopathy.
Francis JH; Harding JJ; Schram AM; Canestraro J; Haggag-Lindgren D; Heinemann M; Kriplani A; Jhaveri K; Voss MH; Bajorin D; Abou-Alfa GK; Iyer G; Drilon A; Rosenberg J; Abramson DH
JAMA Ophthalmol; 2021 Oct; 139(10):1126-1130. PubMed ID: 34473206
[TBL] [Abstract][Full Text] [Related]
5. Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
van Dijk EH; van Herpen CM; Marinkovic M; Haanen JB; Amundson D; Luyten GP; Jager MJ; Kapiteijn EH; Keunen JE; Adamus G; Boon CJ
Ophthalmology; 2015 Sep; 122(9):1907-16. PubMed ID: 26123090
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in chronic central serous chorioretinopathy with subretinal fluid outside the fovea.
van Dijk EHC; Dijkman G; Boon CJF
Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2029-2035. PubMed ID: 28674835
[TBL] [Abstract][Full Text] [Related]
7. OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy.
Borrelli E; Battista M; Sacconi R; Gelormini F; Querques L; Grosso D; Vella G; Bandello F; Querques G
Am J Ophthalmol; 2021 Mar; 223():129-139. PubMed ID: 33342759
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?
Francis JH; Foulsham W; Canestraro J; Harding JJ; Diamond EL; Drilon A; Abramson DH
Ocul Oncol Pathol; 2023 Aug; 9(1-2):25-31. PubMed ID: 38376085
[TBL] [Abstract][Full Text] [Related]
9. CENTRAL SEROUS CHORIORETINOPATHYLIKE MIMICKING MULTIFOCAL VITELLIFORM MACULAR DYSTROPHY: AN OCULAR SIDE EFFECT OF MITOGEN/EXTRACELLULAR SIGNAL-REGULATED KINASE INHIBITORS.
Giuffrè C; Miserocchi E; Modorati G; Carnevali A; Marchese A; Querques L; Querques G; Bandello F
Retin Cases Brief Rep; 2018 Summer; 12(3):172-176. PubMed ID: 27902541
[TBL] [Abstract][Full Text] [Related]
10. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
[TBL] [Abstract][Full Text] [Related]
11. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
12. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
[TBL] [Abstract][Full Text] [Related]
13. Fundus autofluorescence findings in central serous chorioretinopathy using two different confocal scanning laser ophthalmoscopes: correlation with functional and structural status.
Shin JY; Choi HJ; Lee J; Choi M; Chung B; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1537-1544. PubMed ID: 26690973
[TBL] [Abstract][Full Text] [Related]
14. Retinoschisis in eyes with pachychoroid and retinal pigment epithelial atrophy.
Baek J; Lee JH; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2019 Sep; 257(9):1863-1871. PubMed ID: 31222406
[TBL] [Abstract][Full Text] [Related]
15. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with eplerenone to treat chronic central serous chorioretinopathy.
Cakir B; Fischer F; Ehlken C; Bühler A; Stahl A; Schlunck G; Böhringer D; Agostini H; Lange C
Graefes Arch Clin Exp Ophthalmol; 2016 Nov; 254(11):2151-2157. PubMed ID: 27145785
[TBL] [Abstract][Full Text] [Related]
17. FUNDUS AUTOFLUORESCENCE LIFETIMES AND CENTRAL SEROUS CHORIORETINOPATHY.
Dysli C; Berger L; Wolf S; Zinkernagel MS
Retina; 2017 Nov; 37(11):2151-2161. PubMed ID: 28099314
[TBL] [Abstract][Full Text] [Related]
18. Central serous chorioretinopathy in elderly subjects: angiographic and tomographic characteristics.
Bae K; Nam SW; Kang SW; Kim ES; Yu SY; Kim KT; Kim SJ
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):279-288. PubMed ID: 30564905
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Int Ophthalmol; 2017 Jun; 37(3):483-489. PubMed ID: 27392913
[TBL] [Abstract][Full Text] [Related]
20. [Pathophysiology of macular diseases--morphology and function].
Iida T
Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
